FCMD
Food Contact Materials Database
Loxapine succinate
洛沙平琥珀酸酯
,
2-氯-11-(4-甲基哌嗪-1-基)二苯并[b,f][1,4]氧氮杂卓丁二酸盐, 2-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine succinate (1:1), Succinic acid - 2-chloro-11-(4-methyl-1-piperazinyl)dibenzo[b,f][1,4]oxazepine (1:1), Daxolin, Butandisäure--2-chlor-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepin(1:1), loxapine succinate salt, acide butanedioïque - 2-chloro-11-(4-méthylpipérazin-1-yl)dibenzo[b,f][1,4]oxazépine (1:1), MFCD00069298, Loxitane, Cloxazepin, Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-, butanedioate (1:1), Loxapac, EINECS 248-682-0, butanedioic acid,8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine, 2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine butanedioate, Lederle, 2-Chloro-11-(4-methyl-1-piperazinyl)dibenzo[b,f][1,4]oxazepine succinate, Loxapine succinate, Loxapine (succinate)
CAS Number: 27833-64-3
IUPAC name: butanedioic acid;8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine
Molecular formula: C22H24ClN3O5
Molecular weight: 445.896
InChI: InChI=1S/C18H18ClN3O.C4H6O4/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3;1-2H2,(H,5,6)(H,7,8)
InChIKey: YQZBAXDVDZTKEQ-UHFFFAOYSA-N
SMILES: -
EINECS: CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O
One-Click Alert
Download ReportRegions
Filter All
Inventory Categories
Filter All
Sort
By key inventories
By listed
Focused on chemical complianceEmpowering the entire lifecycle of the chemical industry
Substance Information
CAS Number:
27833-64-3
Chemical Name:
Succinic acid, compound with 2-chloro-11-(4-methylpiperazin-1-yl)dibenz[b,f][1,4]oxazepine (1:1)
Chinese name:
Date of inquiry :
Apr 5, 2026
Inquiry website:
https://www.chemradar.com/en/tools/fcmdFCMD inquiry report
| Inventory Name | Country/Region | Status | Obligations |
|---|
ChemRadar
Global chemical compliance information, data and technical service platform
Service Hotline: +353 1 477 3710 (EU) +86 571 8720 6598 (CN) +81 70 9365 8022 (JP) +82 2 6347 8816 (KR)
Disclaimer
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
